Eli Lilly Canada Inc. v. Novopharm Limited, 2010 FC 241 (Olanzapine*)
Justice Zinn - 2010-03-02
Read full decision. Automatically generated summary:
Novopharm Limited (Novopharm) seeks an extraordinary remedy in a unique situation.
Novopharm seeks an order in the nature of a Mareva injunction enjoining Eli Lilly Canada Inc. (Lilly Canada) from transferring its revenues to its parent company, Eli Lilly and Company (Lilly US). In the alternative, Novopharm seeks an order requiring Lilly Canada to post security for damages, that have yet to be quantified, which it asserts it will be awarded pursuant to section 8 of the Patented Medicines (Notice of Compliance) Regulations, SOR/93-133, as amended (the NOC Regulations), and an order that Lilly Canada disclose its financial accounts to Novopharm on a quarterly basis.
Decision relates to:
- T-1048-07 - ELI LILLY CANADA INC. ET AL v. NOVOPHARM LIMITED